Three‐dimensional integrated functional, structural, and computational mapping to define the structural “fingerprints” of heart‐specific atrial fibrillation drivers in human …

J Zhao, BJ Hansen, Y Wang, TA Csepe… - Journal of the …, 2017 - Am Heart Assoc
Background Structural remodeling of human atria plays a key role in sustaining atrial
fibrillation (AF), but insufficient quantitative analysis of human atrial structure impedes the …

Atrial fibrillation driver mechanisms: insight from the isolated human heart

TA Csepe, BJ Hansen, VV Fedorov - Trends in cardiovascular medicine, 2017 - Elsevier
Although there have been great technological advances in the treatment of atrial fibrillation
(AF), current therapies remain limited due to a narrow understanding of AF mechanisms in …

Human atrial fibrillation drivers resolved with integrated functional and structural imaging to benefit clinical mapping

BJ Hansen, J Zhao, N Li, A Zolotarev… - JACC: Clinical …, 2018 - jacc.org
Objectives: This study sought to improve atrial fibrillation (AF) driver identification by
integrating clinical multielectrode mapping with driver fingerprints defined by high-resolution …

Fibrosis and atrial fibrillation: computerized and optical mapping: a view into the human atria at submillimeter resolution

BJ Hansen, J Zhao, VV Fedorov - JACC: Clinical Electrophysiology, 2017 - jacc.org
Recent studies strongly suggest that the majority of atrial fibrillation (AF) patients with
diagnosed or subclinical cardiac diseases have established or even pre-existing fibrotic …

[HTML][HTML] Slow conduction in the border zones of patchy fibrosis stabilizes the drivers for atrial fibrillation: insights from multi-scale human atrial modeling

R Morgan, MA Colman, H Chubb, G Seemann… - Frontiers in …, 2016 - frontiersin.org
Introduction: The genesis of atrial fibrillation (AF) and success of AF ablation therapy have
been strongly linked with atrial fibrosis. Increasing evidence suggests that patient-specific …

Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human …

BJ Hansen, J Zhao, TA Csepe, BT Moore… - European heart …, 2015 - academic.oup.com
Aims The complex architecture of the human atria may create physical substrates for
sustained re-entry to drive atrial fibrillation (AF). The existence of sustained, anatomically …

[HTML][HTML] Atrial heterogeneity generates re-entrant substrate during atrial fibrillation and anti-arrhythmic drug action: mechanistic insights from canine atrial models

M Varela, MA Colman, JC Hancox… - PLoS computational …, 2016 - journals.plos.org
Anti-arrhythmic drug therapy is a frontline treatment for atrial fibrillation (AF), but its success
rates are highly variable. This is due to incomplete understanding of the mechanisms of …

Integration of high-resolution optical mapping and 3-dimensional micro-computed tomographic imaging to resolve the structural basis of atrial conduction in the …

J Zhao, BJ Hansen, TA Csepe, P Lim… - Circulation …, 2015 - Am Heart Assoc
Zhao et al Optical and Micro-CT Mapping of Human Atria 1515 (267 beats per minute),
whereas the LA was passively activated by the Bachmann bundle and septal pathways …

[HTML][HTML] Image-based computational evaluation of the effects of atrial wall thickness and fibrosis on re-entrant drivers for atrial fibrillation

A Roy, M Varela, O Aslanidi - Frontiers in physiology, 2018 - frontiersin.org
Introduction: Catheter ablation (CA) is a common treatment for atrial fibrillation (AF), but the
knowledge of optimal ablation sites, and hence clinical outcomes, are suboptimal …

[HTML][HTML] In silico Comparison of Left Atrial Ablation Techniques That Target the Anatomical, Structural, and Electrical Substrates of Atrial Fibrillation

CH Roney, ML Beach, AM Mehta, I Sim… - Frontiers in …, 2020 - frontiersin.org
Catheter ablation therapy for persistent atrial fibrillation (AF) typically includes pulmonary
vein isolation (PVI) and may include additional ablation lesions that target patient-specific …